Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1373233-11-4
911300-60-2
912849-75-3
1373233-10-3
934164-55-3
1312905-31-9
184576-63-4 | H-D-Orn(boc)-oh | AA00AB6N | MFCD00237206
194862-84-5 | 8-Oxa-2-azaspiro[4.5]decan-3-one | AA00ABFG | MFCD13180589
1446321-46-5 | GBT 440 | AA00ABL8 | MFCD29053764
168165-88-6 | 4-(1,3-Dithian-2-yl)benzoic acid | AA00ABSA | MFCD06208216
193975-33-6 | Ethyl 4-chloro-8-iodoquinoline-3-carboxylate | AA00AC11 | MFCD09991531
16925-15-8 | DIMETHYLBIS(2,4-PENTANEDIONATE)TIN | AA00ACBY | MFCD08275536
154411-16-2 | N-(1-Cyano-4-oxo-4H-quinolizin-3-yl)benzamide | AA00ACQB | MFCD00793861
19564-13-7 | N-Methyl-2-(3-oxo-2-piperazinyl)acetamide | AA00ACVT | MFCD12026519
172476-18-5 | 5-[(7-Chloro-4-quinolinyl)amino]-2-hydroxybenzaldehyde | AA00AD3V | MFCD18816297
19503-22-1 | 1H-Benzotriazole-1-carboxamidine Hydrochloride | AA00AD9S | MFCD18379189